Sanofi India · NSE: SANOFI · BSE: 500674
Q4 FY26 results · Jan–Mar 2026
Sanofi India reported revenue from operations of ₹472.30 crore (down 11.9% from Q4 FY25) and net profit of ₹102.60 crore (down 14.1% from Q4 FY25) for Q4 FY26 (Jan–Mar 2026), on a standalone basis.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 472.30 | 535.90 | −11.9% | 419.80 | +12.5% |
| Other income | 4.40 | 3.30 | +33.3% | 2.80 | +57.1% |
| Total income | 476.70 | 539.20 | −11.6% | 422.60 | +12.8% |
| Profit before tax | 137.90 | 165.30 | −16.6% | 83.00 | +66.1% |
| Net profit for the period | 102.60 | 119.50 | −14.1% | 61.70 | +66.3% |
| EPS, basic (₹) | 44.55 | 51.89 | −14.1% | 26.79 | +66.3% |
| Net margin (%) | 21.7 | 22.3 | 14.7 |
Standalone
- Filed with BSE
- 28 Apr 2026, 18:47 IST
- Board meeting
- 28 Apr 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE